Crocs director Ronald L. Frasch proposes $2.3M sale

The notice lists an aggregate market value of $2,301,855 and an approximate sale date of October 30, 2026.

Available on EDGAR 10/30/2026 - 01:19 PM EDT Accepted by SEC EDGAR 10/30/2026 - 01:19 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Crocs, Inc. (CROX) is identified as the issuer in a Rule 144 notice for Director Ronald L. Frasch’s proposed sale of 15,000 common shares through UBS Financial Services Inc.; the approximate sale date is October 30, 2026. The listed aggregate market value is $2,301,855. The notice also lists earlier common-stock acquisitions as director compensation.

Key Figures

Common shares proposed for sale: 15,000 shares Aggregate market value: $2,301,855 Common shares outstanding: 45,725,039 shares

3 metrics

Common shares proposed for sale 15,000 shares Proposed sale by Ronald L. Frasch

Aggregate market value $2,301,855 Proposed sale

Common shares outstanding 45,725,039 shares Crocs, Inc.

Key Terms

Rule 144, attorney-in-fact, Director Compensation

3 terms

Rule 144 regulatory

"definition of “person” in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

attorney-in-fact regulatory

"as attorney-in-fact for Ronald L Frasch"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

Director Compensation financial

"Director Compensation"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CROX shares does Ronald L. Frasch propose to sell?

Ronald L. Frasch, a Director, lists a proposed sale of 15,000 Crocs common shares through UBS Financial Services Inc. The notice gives an aggregate market value of $2,301,855 and an approximate sale date of October 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001160547
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Crocs, Inc.
SEC File Number	000-51754
Address of Issuer	500 Eldorado Blvd, Building 5 Broomfield COLORADO 80021
Phone	303-848-7171
Name of Person for Whose Account the Securities are To Be Sold	Ronald L Frasch
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	15000	2301855	45725039	10/30/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/08/2015	Director Compensation	Crocs, Inc.			6667	06/08/2015	Stock
Common Stock	03/13/2014	Director Compensation	Crocs, Inc.			1170	03/13/2014	Stock
Common Stock	01/27/2014	Director Compensation	Crocs, Inc.			3760	01/27/2014	Stock
Common Stock	06/13/2014	Director Compensation	Crocs, Inc.			1170	06/13/2014	Stock
Common Stock	09/08/2015	Director Compensation	Crocs, Inc.			1333	09/08/2015	Stock
Common Stock	09/13/2013	Director Compensation	Crocs, Inc.			30	09/13/2013	Stock
Common Stock	11/21/2014	Director Compensation	Crocs, Inc.			870	11/21/2014	Stock

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	10/30/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Ronald L Frasch
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)